Danaher Corporation, headquartered in Washington, D.C., is a globally diversified conglomerate specializing in life sciences and diagnostics. Founded in 1984 by Steven and Mitchell Rales, it has grown significantly through strategic acquisitions, including Abcam in 2024. With 65,000 employees worldwide, Danaher is dedicated to continuous improvement and sustainability, aiming for net-zero emissions by 2050. The company also collaborates on pioneering healthcare projects, such as developing CRISPR-based therapies.